Oncolytics Biotech announced that Dr. Rita Laeufle, M.D., Ph.D., who has been working as a consultant for Oncolytics for the last four months, has been appointed as chief medical officer.  Dr. Laeufle will oversee the clinical development plan for pelareorep as the company drives towards a registration study in breast cancer. “Dr. Laeufle brings a tremendous track record in clinical advancement to Oncolytics, including an approval in the treatment of metastatic breast cancer,” said Dr. Ma...